2 weeks Ago By ABMN Staff
Renaissance Technologies LLC increased its stake in shares of Fortrea Holdings Inc. ( NASDAQ:FTRE – Free Report ) by 2,996.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 321,982 shares of the company’s stock after buying an additional 311,582 shares during the quarter. Renaissance Technologies LLC’s holdings in Fortrea were worth $6,005,000 at the end of the most recent reporting period. Other hedge funds have also recently added to or reduced their stakes in the company.
Invesco Ltd. lifted its position in shares of Fortrea by 20.5% during the 4th quarter.
Invesco Ltd. now owns 546,160 shares of the company’s stock worth $10,186,000 after buying an additional 92,774 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Fortrea by 53.
7% in the 4th quarter. Bank of Montreal Can now owns 21,983 shares of the company’s stock valued at $410,000 after purchasing an additional 7,677 shares in the last quarter. FMR LLC grew its holdings in shares of Fortrea by 67.
7% during the 4th quarter. FMR LLC now owns 8,086,806 shares of the company’s stock valued at $150,819,000 after purchasing an additional 3,265,402 shares during the last quarter. Russell Investments Group Ltd.
lifted its stake in Fortrea by 20.8% in the 4th quarter. Russell Investments Group Ltd.
now owns 219,365 shares of the company’s stock valued at $4,091,000 after purchasing an additional 37,744 shares during the last quarter. Finally, Bryce Point Capital LLC acquired a new stake in Fortrea in the fourth quarter valued at approximately $308,000. Fortrea Stock Performance NASDAQ FTRE opened at $5.
29 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.
18 and a quick ratio of 1.18. The company has a fifty day moving average price of $9.
76 and a 200-day moving average price of $15.70. Fortrea Holdings Inc.
has a 1 year low of $4.77 and a 1 year high of $38.04.
The firm has a market cap of $477.16 million, a price-to-earnings ratio of -1.55, a PEG ratio of 1.
78 and a beta of 2.10. Analyst Ratings Changes FTRE has been the subject of a number of research reports.
Barclays reiterated an “underweight” rating and issued a $6.00 price objective (down previously from $12.00) on shares of Fortrea in a report on Thursday, April 10th.
Mizuho cut their target price on Fortrea from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, April 9th.
The Goldman Sachs Group lowered their price objective on Fortrea from $22.00 to $11.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th.
William Blair reissued a “market perform” rating on shares of Fortrea in a research report on Tuesday, March 4th. Finally, Evercore ISI reduced their price objective on shares of Fortrea from $20.00 to $15.
00 and set an “in-line” rating on the stock in a research note on Tuesday, March 4th. Two research analysts have rated the stock with a sell rating and ten have given a hold rating to the company. According to MarketBeat.
com, the company currently has a consensus rating of “Hold” and an average target price of $16.70. Check Out Our Latest Stock Analysis on Fortrea Fortrea Profile ( Free Report ) Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide.
The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. Featured Articles Want to see what other hedge funds are holding FTRE? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Fortrea Holdings Inc. ( NASDAQ:FTRE – Free Report ). Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.
com's FREE daily email newsletter ..
